{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:17:09Z","timestamp":1791037029963,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.ygyno.2010.12.354","type":"journal-article","created":{"date-parts":[[2011,1,29]],"date-time":"2011-01-29T04:17:08Z","timestamp":1296274628000},"page":"358-363","source":"Crossref","is-referenced-by-count":29,"title":["Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations"],"prefix":"10.1016","volume":"121","author":[{"given":"Robin A.","family":"Lacour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon N.","family":"Westin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shana N.","family":"Wingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John O.","family":"Schorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sutphen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mack","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bethan","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Choubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather R.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana L.","family":"Urbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Bodurka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Gershenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2010.12.354_bb0005","series-title":"Principles and practice of gynecologic oncology","first-page":"895","article-title":"Epithelial ovarian cancer","author":"Ozols","year":"2005"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0010","doi-asserted-by":"crossref","DOI":"10.3322\/caac.20073","article-title":"Cancer Statistics, 2010","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0015","unstructured":"Centers for Disease Control. Ovarian Cancer Control Initiative from the National Center for Chronic Disease Prevention and Health Promotion; 2010 [updated 2010 May 26; cited 2010 Aug 4]. Available from: http:\/\/www.cdc.gov\/cancer\/ovarian\/index.htm"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0020","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1006\/gyno.2002.6674","article-title":"Specific keynote: hereditary ovarian cancer: what we know","volume":"88","author":"Boyd","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0025","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0030","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","article-title":"Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13","volume":"61","author":"Easton","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0035","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ygyno.2010.12.354_bb0040","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0045","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1086\/302853","article-title":"BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer","volume":"66","author":"Moslehi","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0050","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"The New York Breast Cancer Study Group. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0055","unstructured":"National Cancer Institute. Genetics of Breast and Ovarian Cancer; 2010 [updated 2010 July 22; cited 2010 Aug 4]. Available from: http:\/\/www.cancer.gov\/cancertopics\/pdq\/genetics\/breast-and-ovarian"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0060","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA."},{"key":"10.1016\/j.ygyno.2010.12.354_bb0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/JCO.20.2.463","article-title":"Effect of BRCA mutations n length of survival in epithelial ovarian tumors","volume":"20","author":"Bendavid","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.2007.11.6905","article-title":"Effects of BRCA 1\/2 mutations on long- term survival of patients with invasive ovarian cancer: The National Israeli Study of Ovarian Cancer","volume":"26","author":"Chetrit","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2010.12.354_bb0075","first-page":"868","article-title":"Survival in familial, BRCA1-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group","volume":"59","author":"Pharoah","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2010.12.354_bb0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0301-2115(01)00318-9","article-title":"Survival analysis in familial ovarian cancer, a case control study","volume":"98","author":"Zweemer","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"10.1016\/j.ygyno.2010.12.354_bb0085","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1200\/JCO.2008.16.1703","article-title":"\u201dBRCAness\u201d Syndrome in Ovarian Cancer: a control- control study describing the clinical features and outcomes of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations","volume":"26","author":"Tan","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ygyno.2010.12.354_bb0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1200\/JCO.1998.16.2.397","article-title":"Survival of BRCA1 breast and ovarian cancer patients: a population-based study from Southern Sweden","volume":"16","author":"Johannsson","year":"1998","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ygyno.2010.12.354_bb0095","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2008.19.1684","article-title":"Evaluation of new platinum- based treatment regimens in advanced- stage ovarian cancer: A phase III trial of the Gynecologic Cancer InterGroup","volume":"27","author":"Bookman","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ygyno.2010.12.354_bb0100","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","article-title":"Clinical and pathologic features of ovarian cancer in women with germline mutations of BRCA1","volume":"335","author":"Rubin","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ygyno.2010.12.354_bb0105","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/cncr.11310","article-title":"Improved survival in women with BRCA-associated ovarian cancer","volume":"97","author":"Cass","year":"2003","journal-title":"Cancer."},{"key":"10.1016\/j.ygyno.2010.12.354_bb0110","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10, 000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ygyno.2010.12.354_bb0115","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810012618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810012618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T02:20:32Z","timestamp":1559960432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825810012618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0090825810012618"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.12.354","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}